🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

145,35 USD

Máx. histórico

185,50

95 días

Caída desde máximo

-21,64%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-0,51%

Cierre anterior

146,10

Rango de hoy

143,75 – 147,57

Volumen hoy

1.987.253

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,27%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
21,31 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
206,22 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/09/2026 146,15 146,26 143,45 143,96 -1,55% 1,92% 1.385.300
18/09/2026 152,63 152,63 146,06 146,23 -3,69% 4,30% 2.815.400
17/09/2026 151,14 152,07 149,71 151,83 +1,56% 1,56% 1.178.300
16/09/2026 150,34 151,31 149,00 149,50 -0,35% 1,54% 1.015.400
15/09/2026 156,70 156,70 149,15 150,02 -4,58% 4,82% 1.332.100
14/09/2026 158,00 159,19 156,57 157,22 +0,64% 1,66% 785.500
11/09/2026 157,20 159,67 156,12 156,22 -0,22% 2,26% 890.900
10/09/2026 154,38 159,94 152,04 156,57 +0,92% 5,12% 895.200
09/09/2026 154,61 155,55 152,38 155,14 +0,01% 2,05% 1.050.700
08/09/2026 153,99 156,82 151,77 155,13 -0,33% 3,28% 818.700
04/09/2026 158,24 159,80 154,83 155,64 -1,71% 3,14% 933.400
03/09/2026 159,93 159,93 156,76 158,35 +0,35% 1,98% 758.300
02/09/2026 157,39 160,43 155,09 157,79 +0,66% 3,39% 1.037.900
01/09/2026 154,31 157,03 153,70 156,76 +1,77% 2,16% 878.400
31/08/2026 153,11 155,00 151,77 154,03 -0,02% 2,11% 1.741.100
28/08/2026 155,92 156,57 153,08 154,06 -1,19% 2,24% 813.000
27/08/2026 155,28 156,75 154,61 155,92 -0,43% 1,38% 730.300
26/08/2026 153,21 159,40 152,02 156,59 +2,10% 4,82% 1.119.100
25/08/2026 153,84 156,13 152,01 153,37 +0,22% 2,68% 1.041.800
24/08/2026 152,57 154,56 151,77 153,04 +0,31% 1,83% 1.207.500
21/08/2026 153,13 155,27 152,51 152,57 -0,24% 1,80% 1.227.600
20/08/2026 154,99 155,81 152,50 152,93 -1,68% 2,14% 870.700
19/08/2026 156,56 156,56 154,34 155,54 +0,85% 1,42% 1.162.800
18/08/2026 155,92 156,24 153,46 154,23 -0,17% 1,78% 1.037.500
17/08/2026 151,62 154,81 150,69 154,49 +1,16% 2,72% 1.169.000
14/08/2026 149,72 153,42 148,78 152,72 +1,26% 3,10% 1.305.100
13/08/2026 154,43 155,81 150,20 150,82 -3,62% 3,63% 2.055.700
12/08/2026 159,74 159,98 154,86 156,49 -3,37% 3,21% 2.094.100
11/08/2026 165,46 165,46 161,78 161,94 -1,81% 2,22% 808.100
10/08/2026 161,52 165,15 161,52 164,92 +0,92% 2,25% 935.200